CIK: 0001586444
Total reported value
$146.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | COO | The Cooper Companies, Inc. | Stock-Healthcare | 9.13% | — | +2.99% | |
| 2 | ✓ | Stock-Other | 9.04% | — | — | ||
| 3 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 9.02% | +4.55% | NEW | |
| 4 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 8.25% | — | — | |
| 5 | IART | Integra Lifesciences Holding | Stock-Other | 7.75% | — | — | |
| 6 | ABMDEUR | Abiomed INC | Stock-Other | 7.49% | +0.79% | — | |
| 7 | QGEN | Qiagen N.V. | Stock-Healthcare | 6.79% | -5.55% | EXIT | |
| 8 | ✓ | St Jude Med INC | Stock-Other | 6.69% | — | +24.68% | |
| 9 | A | Agilent Technologies INC | Stock-Healthcare | 6.37% | — | -12.28% | |
| 10 | ✓ | Shire PLC | Stock-Other | 4.96% | — | -50.94% | |
| 11 | DGX | Quest Diagnostics INC | Stock-Healthcare | 4.25% | — | -46.93% | |
| 12 | PDCOEUR | Patterson Cos INC | Stock-Other | 4.24% | — | — | |
| 13 | MASI* | Masimo CORP | Stock-Other | 4.11% | — | -28.58% | |
| 14 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 4.01% | — | — | |
| 15 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 3.96% | +1.31% | — | |
| 16 | INCY | Incyte CORP | Stock-Healthcare | 3.94% | +1.60% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NBIX | Neurocrine Biosciences INC | +5.2% | +78.20% | Add |
| 2 | COO | The Cooper Companies, Inc. | +5.1% | +2.99% | Add |
| 3 | ✓ | St Jude Med INC | +3.5% | +24.68% | Add |
| 4 | QGEN | Qiagen N.V. | +3.4% | +31.94% | Add |
| 5 | A | Agilent Technologies INC | +2.4% | -12.28% | Trim |
| 6 | MASI* | Masimo CORP | +1.1% | -28.58% | Trim |
| 7 | DGX | Quest Diagnostics INC | +0.1% | -46.93% | Trim |
| 8 | ✓ | Shire PLC | -1.4% | -50.94% | Trim |
| 9 | ISRG | Intuitive Surgical INC | — | EXIT | Sold out |
| 10 | EW | Edwards Lifesciences CORP | — | EXIT | Sold out |
| 11 | BIIB | Biogen INC | — | EXIT | Sold out |
| 12 | ✓ | — | EXIT | Sold out | |
| 13 | ✓ | — | EXIT | Sold out | |
| 14 | ✓ | — | NEW | New buy | |
| 15 | CERNCHF | Cerner CORP | — | EXIT | Sold out |
| 16 | IONS | Ionis Pharmaceuticals INC | — | NEW | New buy |
| 17 | NVROEUR | Nevro CORP | — | EXIT | Sold out |
| 18 | IPXLEUR | Impax Laboratories INC | — | EXIT | Sold out |
| 19 | HO1 | Hologic INC | — | EXIT | Sold out |
| 20 | IART | Integra Lifesciences Holding | — | NEW | New buy |
| 21 | ABMDEUR | Abiomed INC | — | NEW | New buy |
| 22 | BMY | Bristol-myers Squibb Co | — | EXIT | Sold out |
| 23 | ✓ | Wright Medical Group NV | — | EXIT | Sold out |
| 24 | ✓ | Cepheid | — | EXIT | Sold out |
| 25 | VRTX | Vertex Pharmaceuticals INC | — | EXIT | Sold out |
| 26 | ✓ | Depomed INC | — | EXIT | Sold out |
| 27 | PRGO | Perrigo Company plc | — | EXIT | Sold out |
| 28 | PDCOEUR | Patterson Cos INC | — | NEW | New buy |
| 29 | ALXN | Alexion Pharmaceuticals INC | — | NEW | New buy |
| 30 | BMRN | Biomarin Pharmaceutical INC | — | NEW | New buy |
| 31 | INCY | Incyte CORP | — | NEW | New buy |